{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:28:17Z","timestamp":1778498897835,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T00:00:00Z","timestamp":1363219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Until the 1990s, basal cell carcinoma (<jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content>) was viewed as the most common epithelial neoplasm developing in association with nevus sebaceus (<jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>). Currently, trichoblastoma is thought of as the most prevalent basaloid neoplasm in <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>. The follicular stem cell marker pleckstrin homology\u2010like domain, family A, member 1 (<jats:styled-content style=\"fixed-case\">PHLDA1<\/jats:styled-content>) also known as T\u2010cell death\u2010associated gene 51 (<jats:styled-content style=\"fixed-case\">TDAG51<\/jats:styled-content>) labels trichoepithelioma (TE) but not <jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content>. Therefore, we explored its usefulness in basaloid neoplasms developing in <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We studied immunohistochemically <jats:styled-content style=\"fixed-case\">PHLDA1<\/jats:styled-content> in 10 nodular <jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content>s, 11 TEs, 11 trichoblastomas and 25 <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content> with basaloid tumors. Additionally, we examined the expression of <jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content> marker <jats:styled-content style=\"fixed-case\">BerEP4<\/jats:styled-content> and the distribution of Merkel cells that function as surrogate markers for benign follicular neoplasms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nineteen of the 25 basaloid tumors in <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content> were <jats:styled-content style=\"fixed-case\">PHLDA1<\/jats:styled-content>\u2010negative comparable to <jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content> arising <jats:italic>de novo<\/jats:italic> and six tumors were <jats:styled-content style=\"fixed-case\">PHLDA1<\/jats:styled-content>\u2010positive comparable to solitary trichoblastomas and TEs. Fewer Merkel cells were seen in <jats:styled-content style=\"fixed-case\">BCCs<\/jats:styled-content> associated with <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content> when compared with trichoblastoma. <jats:styled-content style=\"fixed-case\">BerEP4<\/jats:styled-content> did not discriminate between the neoplasms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We raise concern that the unquestioned assessment that basaloid tumors developing in association with <jats:styled-content style=\"fixed-case\">NS<\/jats:styled-content> represent mostly trichoblastomas and not <jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content> may not be true. This influences clinical care, as it is paramount in the decision of whether to excise these lesions or not.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cup.12107","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T02:48:26Z","timestamp":1363315706000},"page":"455-462","source":"Crossref","is-referenced-by-count":26,"title":["Basaloid tumors in nevus sebaceus revisited: the follicular stem cell marker <scp>PHLDA1<\/scp> (<scp>TDAG51<\/scp>) indicates that most are basal cell carcinomas and not trichoblastomas"],"prefix":"10.1111","volume":"40","author":[{"given":"Klaus","family":"Sellheyer","sequence":"first","affiliation":[{"name":"Department of Dermatology Cleveland Clinic Foundation  Cleveland OH USA"},{"name":"Nelson Dermatopathology Associates  Atlanta GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Cribier","sequence":"additional","affiliation":[{"name":"Clinique Dermatologique H\u00f4pitaux Universitaires de Strasbourg  Strasbourg France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Nelson","sequence":"additional","affiliation":[{"name":"Nelson Dermatopathology Associates  Atlanta GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Kutzner","sequence":"additional","affiliation":[{"name":"Dermatopathologie Friedrichshafen  Friedrichshafen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno","family":"R\u00fctten","sequence":"additional","affiliation":[{"name":"Dermatopathologie Friedrichshafen  Friedrichshafen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,14]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1965.01600120006002"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-198602000-00005"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1970.tb15000.x"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1985.tb01623.x"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1985.tb02893.x"},{"key":"e_1_2_5_7_1","volume-title":"Neoplasms with follicular differentiation","author":"Ackerman AB","year":"1993"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90136-1"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200004000-00004"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2000.027007327.x"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050214"},{"key":"e_1_2_5_12_1","first-page":"94","volume-title":"Differential diagnosis in dermatopathology III","author":"Ackerman AB","year":"1993"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199512000-00008"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07036_supp.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2011.01693.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10045.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10612.x"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000138051.71415.fe"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199310000-00007"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01235.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2006.00409.x"},{"key":"e_1_2_5_22_1","first-page":"1733","volume-title":"Dermatology","author":"McCalmont TH","year":"2003"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70220-6"},{"key":"e_1_2_5_24_1","first-page":"450","article-title":"Immunohistochemical staining for Ber\u2010EP4, p53, proliferating cell nuclear antigen, Ki\u201067, bcl\u20102, CD34, and factor XIIIa in nevus sebaceus","volume":"12","author":"Barrett TL","year":"1999","journal-title":"Mod Pathol"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26043"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11165.x"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2006.00710.x"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2011.01494.x"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcup.12107","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cup.12107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T17:24:13Z","timestamp":1700673853000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cup.12107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/cup.12107"],"URL":"https:\/\/doi.org\/10.1111\/cup.12107","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}